What is the recommended first‑line intravenous antibiotic regimen and duration for an adult with a clinically infected dog‑bite wound, including alternatives for β‑lactam allergy and renal impairment?

Intravenous Antibiotic Therapy for Infected Dog Bite Wounds

First-Line IV Regimen

For adults with clinically infected dog bite wounds requiring hospitalization, initiate ampicillin-sulbactam, piperacillin-tazobactam, or a carbapenem (ertapenem, imipenem, or meropenem) as first-line intravenous therapy. 1, 2

These β-lactam/β-lactamase inhibitor combinations and carbapenems provide comprehensive coverage against the polymicrobial flora typical of dog bites, including:

• Pasteurella species (present in 50% of dog bite wounds) 1
• Staphylococcus aureus and Streptococcus species (each found in ~40% of wounds) 1
• Anaerobes including Bacteroides, Fusobacterium, Porphyromonas, and Prevotella species 1
• Capnocytophaga canimorsus, particularly concerning in asplenic or hepatic disease patients 1, 2

Alternative IV options include second-generation cephalosporins (cefoxitin) or third-generation cephalosporins (ceftriaxone) plus metronidazole. 1, 2

β-Lactam Allergy Alternatives

For patients with documented penicillin allergy, use vancomycin 15-20 mg/kg IV every 8-12 hours PLUS ceftriaxone 1-2 g IV daily PLUS metronidazole 500 mg IV every 8 hours. 2

This triple-drug regimen is necessary because:

• Vancomycin covers MRSA (isolated in ~40% of dog bite wounds) 2
• Ceftriaxone provides gram-negative coverage including Pasteurella 2
• Metronidazole ensures anaerobic coverage 2

Alternative for β-lactam allergy: Vancomycin 15-20 mg/kg IV every 8-12 hours PLUS levofloxacin 750 mg IV daily PLUS metronidazole 500 mg IV every 8 hours. 2

Critical Caveat for Allergy Management

Most reported penicillin "allergies" are not true IgE-mediated reactions. 3 However, avoid testing or re-challenging patients with histories of Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS syndrome, severe hepatitis, interstitial nephritis, or hemolytic anemia. 3

Renal Impairment Adjustments

For patients with renal dysfunction, dose adjustments are required:

• Ertapenem: Reduce to 500 mg IV daily if CrCl <30 mL/min 1
• Piperacillin-tazobactam: Adjust based on creatinine clearance per standard dosing guidelines 1
• Vancomycin: Dose based on renal function and therapeutic drug monitoring (target trough 15-20 mcg/mL) 2
• Levofloxacin: Reduce dose if CrCl <50 mL/min 2

Treatment Duration Algorithm

Initial IV therapy: 3-5 days for patients with systemic symptoms, moderate-to-severe infections, or high-risk wounds (hand involvement, joint/bone penetration, immunocompromised status). 2

Transition to oral therapy when the patient is afebrile, systemic symptoms resolve, and local infection signs improve. 2

Total antimicrobial duration:

• 7-10 days for uncomplicated soft tissue infections 2
• 3-4 weeks for septic arthritis 1, 2
• 4-6 weeks for osteomyelitis 1, 2

Oral Step-Down Options

After clinical improvement on IV therapy, transition to:

• Amoxicillin-clavulanate 875/125 mg twice daily (preferred) 1, 2
• Doxycycline 100 mg twice daily (excellent Pasteurella coverage, safe in penicillin allergy) 2
• Moxifloxacin as monotherapy 2
• Clindamycin plus a fluoroquinolone 2

High-Risk Features Requiring Aggressive Management

Hospitalization and IV antibiotics are indicated when ANY of the following are present:

• Hand, wrist, foot, face, or genital location 2
• Wounds penetrating periosteum or joint capsule 1, 2
• Immunocompromised status, asplenia, or advanced liver disease 1, 2
• Pre-existing or resultant edema of the affected area 2
• Failed outpatient oral therapy 2
• Systemic signs: fever, increasing pain/swelling, purulent drainage 2

Hand wounds are particularly serious and often require longer treatment courses due to the risk of tendonitis, septic arthritis, and osteomyelitis. 1

Critical Pitfalls to Avoid

Never use first-generation cephalosporins (cephalexin), macrolides (erythromycin), penicillinase-resistant penicillins (dicloxacillin), or clindamycin as monotherapy – these agents have poor activity against Pasteurella multocida and will result in treatment failure. 1, 2

Obtain aerobic and anaerobic wound cultures before initiating antibiotics to allow targeted therapy based on microbiology results. 2

Essential Adjunctive Management

Beyond antibiotics, aggressive wound management is critical:

• Immediate incision and drainage of any purulent collection (primary treatment for source control) 2
• Copious irrigation with sterile normal saline 1, 4
• Debridement of necrotic tissue 2
• Wound exploration to assess for tendon, bone, or joint involvement 2
• Elevation of the affected extremity to accelerate healing 1
• Tetanus prophylaxis if not current within 10 years 2
• Rabies prophylaxis consultation with local health officials 2

Do not close infected wounds – this traps bacteria and worsens outcomes. 1